ABOUT US
COMPANY'S PROFILE
The company was founded in 2007. It is specialized in the identification of novel autoantigens and biomarkers of human diseases and the development of enhanced performance immunoassays for the detection of humoral and cellular immune responses with diagnostic and prognostic significance.
One of its main goals is to develop simple, single tests able to replace conventional immunoassays used for the detection of disease-specific antigens and biomarkers and monitoring of immunological reactivities as indexes of disease status, response to vaccines or therapeutical approaches (immune-mediated anti-cancer and anti-viral treatment).
Our human resources encompass a multi-disciplinary group of academics, and researchers with a special interest in molecular and cellular immunobiology and cancerous biomarker techonology developed in UK, Germany and USA.
The scientific team is srongly associated with an experienced project management team aiming at achieving an advance in science and technology and procuring customised Research and Development applications for its clients.